Science Explorer Interactive view Map
Company · Rochester · United States

Vaccinex (United States)

vaccinex.comROR OpenAlex
Research works
68
▼ 21% vs 2013–17
Citations
1.4k
20.7 per fractional work
Top-10% rate
7.9%
record average 16.5%
Open access
38%
world 28%

Not ranked overall: Vaccinex (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.18× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.86× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 28.60× its world share, 4 worksImmunology and Micro…Neuroscience: 14.82× its world share, 4 worksNeuroscienceComputer Science: 0.02× its world share, 0 worksComputer ScienceMedicine: 1.58× its world share, 5 worksMedicineSocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 28.6×. Every wedge is a field page.

Who are the top researchers at Vaccinex (United States)?

Ranked on the composite score, John E. Leonard, Maurice Zauderer and Terrence L. Fisher lead among researchers whose main affiliation is Vaccinex (United States).

  1. 1 John E. Leonard United States · #377,848 worldwide 85 citations · 21 works
  2. 2 Maurice Zauderer United States · #1,264,719 worldwide 17 citations · 21 works
  3. 3 Terrence L. Fisher United States · #1,410,847 worldwide 1 citations · 17 works
  4. 4 Elizabeth E. Evans United States · #1,537,712 worldwide 9 citations · 16 works
All ranked researchers at Vaccinex (United States)

Which keywords describe research at Vaccinex (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Receptor tyrosine kinases, Cell Signaling, Eph receptors, Semaphorins, Cancer Immunotherapy, endothelial progenitor cells, VEGF and Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Receptor tyrosine kinases14▲ 466×2 topics
  2. Cell Signaling14▲ 60×3 topics
  3. Eph receptors13▲ 1409×1 topic
  4. Semaphorins13▲ 1409×1 topic
  5. Cancer Immunotherapy7▲ 71×3 topics
  6. VEGF5▲ 226×1 topic
  7. endothelial progenitor cells5▲ 226×1 topic
  8. Immunity5▲ 21×6 topics
  9. Immunotherapy4▲ 10×9 topics
  10. Epidemiology4▲ 1.63×19 topics
  11. Inflammation4▲ 2.8×12 topics
  12. Glycosylation4▲ 29×3 topics
  13. Cancer3▲ 3.6×9 topics
  14. Monoclonal Antibodies3▲ 34×3 topics
  15. Innate Immunity3▲ 13×4 topics
  16. Therapeutic Antibodies3▲ 36×2 topics
  17. Autoimmunity3▲ 21×4 topics
  18. Angiogenesis3▲ 10×5 topics
  19. Antibody Engineering3▲ 41×1 topic
  20. Antigen Presentation3▲ 41×2 topics
  21. Fc Receptors3▲ 41×1 topic
  22. Dendritic Cells2▲ 33×1 topic
  23. Lymphoma2▲ 25×3 topics
  24. Tumor Antigen2▲ 46×1 topic
  25. Tumor Regression2▲ 40×2 topics
  26. CAR T Cells2▲ 75×1 topic
  27. Chimeric Antigen Receptor2▲ 75×1 topic
  28. NK Cell Recognition2▲ 32×1 topic
  29. Natural Killer Cells2▲ 32×1 topic
  30. CD472▲ 190×1 topic
  31. Foxp32▲ 40×1 topic
  32. Immune Response2▲ 4.8×9 topics
  33. TGF-ß2▲ 17×1 topic
  34. apoptotic cells2▲ 190×1 topic
  35. Tumor Microenvironment2▲ 7.9×3 topics
  36. Mitochondrial Dysfunction2▲ 7.3×4 topics
  37. Monoclonal Antibody2▲ 37×2 topics
  38. Neuroprotective2▲ 18×2 topics
  39. Protein Aggregation2▲ 27×2 topics
  40. Targeted Therapy2▲ 10×5 topics

Which research topics does Vaccinex (United States) publish most on?

By volume in 2022–2025: Axon Guidance and Neuronal Signaling, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses and Cancer Immunotherapy and Biomarkers.

Axon Guidance and Neuronal Signaling: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksGenetic Neurodegenerative Diseases: 1 fractional worksCAR-T cell therapy research: 1 fractional worksT-cell and B-cell Immuno…1T-cell and B-cell Immunology: 1 fractional worksImmune Cell Function and Interaction: 1 fractional worksPhagocytosis and Immune Regulation: 1 fractional worksMitochondrial Function and Pathology: 0 fractional works
Cellular and Molecular NeuroscienceRadiology, Nuclear Medicine and ImagingImmunologyOncology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Axon Guidance and Neuronal Signaling Cellular and Molecular Neuroscience 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  3. 3 Immunotherapy and Immune Responses Immunology 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works
  6. 6 CAR-T cell therapy research Oncology 1 works
  7. 7 T-cell and B-cell Immunology Immunology 1 works
  8. 8 Immune Cell Function and Interaction Immunology 1 works
  9. 9 Phagocytosis and Immune Regulation Immunology 1 works
  10. 10 Mitochondrial Function and Pathology Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.1%not open61.9%

World: 28% of research is openly available.

with international co-authors11.0%domestic only89.0%

World: 19% is written across borders.

How has Vaccinex (United States)'s research output changed?

Output in 2018–2022 was 21% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rochester

All research institutions in Rochester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.